The FDA on Thursday approved Fabhalta (iptacopan) to treat complement 3 glomerulopathy (CG3), a progressive, ultrarare kidney ...

Investigators assessed frailty prevalence in a nationally representative US cohort and inpatient outcomes among kidney transplant recipients.

The following is a summary of “Construction of a machine learning-based interpretable prediction model for acute kidney ...

The use of an AI-powered risk assessment tool cut the average length of stay for patients undergoing cardiac catheterization ...

Up to 30% of acute kidney injury (AKI) survivors requiring dialysis and personalized care after discharge from the hospital.

The following is a summary of “Incidence of Acute Kidney Injury After Exposure to Intravenous Contrast in Emergency ...

FILSPARI REMS: Due to the risk of hepatotoxicity and embryo-fetal toxicity, FILSPARI is available only through a restricted program called the FILSPARI REMS. Prescribers, patients, and pharmacies must ...

Patients with acute kidney injury requiring temporary hemodialysis often follow the protocol used for people on long-term ...

Painkillers, especially of the NSAID family, are known for causing kidney diseases, when consumed in excess. Know the ...

March 13 marks the World Kidney Day, a special moment to remember the importance of kidney health and the urgent need to address kidney-related diseases that affect millions worldwide. This year’s ...